Ghent University Academic Bibliography

Advanced

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study

Ivan Borbath, Antonio Ceratti, Chris Verslype, Anne Demols, Thierry Delaunois, Stéphanie Laurent UGent, Amélie Deleporte, Philippe Vergauwe, Eric Van Cutsem and Jean-Luc Van Laethem (2011) JOURNAL OF CLINICAL ONCOLOGY. 29(4, suppl.).
Please use this url to cite or link to this publication:
author
organization
year
type
conference
publication status
published
subject
in
JOURNAL OF CLINICAL ONCOLOGY
J. Clin. Oncol.
volume
29
issue
4, suppl.
conference name
2011 ASCO Gastrointestinal Cancers symposium
conference location
San Francisco, CA, USA
conference start
2011-01-20
conference end
2011-01-22
JCR category
ONCOLOGY
JCR impact factor
18.372 (2011)
JCR rank
5/190 (2011)
JCR quartile
1 (2011)
ISSN
0732-183X
language
English
UGent publication?
yes
classification
C3
additional info
uploaded document is poster version
copyright statement
I have retained and own the full copyright for this publication
id
2047787
handle
http://hdl.handle.net/1854/LU-2047787
date created
2012-02-27 16:34:11
date last changed
2012-03-14 14:12:50
@inproceedings{2047787,
  author       = {Borbath, Ivan  and Ceratti, Antonio and Verslype, Chris and Demols, Anne and Delaunois, Thierry and Laurent, St{\'e}phanie and Deleporte, Am{\'e}lie and Vergauwe, Philippe and Van Cutsem, Eric and Van Laethem, Jean-Luc },
  booktitle    = {JOURNAL OF CLINICAL ONCOLOGY},
  issn         = {0732-183X},
  language     = {eng},
  location     = {San Francisco, CA, USA},
  number       = {4, suppl.},
  title        = {Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study},
  volume       = {29},
  year         = {2011},
}

Chicago
Borbath, Ivan , Antonio Ceratti, Chris Verslype, Anne Demols, Thierry Delaunois, Stéphanie Laurent, Amélie Deleporte, Philippe Vergauwe, Eric Van Cutsem, and Jean-Luc Van Laethem. 2011. “Combination of Gemcitabine and Cetuximab in Patients with Advanced Cholangiocarcinoma: a Phase II Study.” In Journal of Clinical Oncology. Vol. 29.
APA
Borbath, I., Ceratti, A., Verslype, C., Demols, A., Delaunois, T., Laurent, S., Deleporte, A., et al. (2011). Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study. JOURNAL OF CLINICAL ONCOLOGY (Vol. 29). Presented at the 2011 ASCO Gastrointestinal Cancers symposium.
Vancouver
1.
Borbath I, Ceratti A, Verslype C, Demols A, Delaunois T, Laurent S, et al. Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study. JOURNAL OF CLINICAL ONCOLOGY. 2011.
MLA
Borbath, Ivan , Antonio Ceratti, Chris Verslype, et al. “Combination of Gemcitabine and Cetuximab in Patients with Advanced Cholangiocarcinoma: a Phase II Study.” Journal of Clinical Oncology. Vol. 29. 2011. Print.